What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Throughput Single Cell Sequencing market?

Advances in technology and increasing demand for personalized medicine drive the market.

What are the major challenges facing the market?

High costs and limited accessibility of single cell sequencing technologies are major challenges.

Which regions are leading the Throughput Single Cell Sequencing market?

North America and Europe are currently leading the market due to high adoption rates.

Who are the top companies in the Throughput Single Cell Sequencing market?

Illumina, Thermo Fisher Scientific, and Becton Dickinson are among the top companies in the market.

What future opportunities exist in the market?

Emerging applications in cancer research and regenerative medicine offer future opportunities.

How will technology impact the future outlook of the market?

Advances in AI and machine learning will enhance data analysis and drive market growth.

What is the current regulatory landscape for the market?

Stringent regulations and standards for data privacy and security are in place.

How will the market size change in the next 5 years?

The market size is expected to reach USD 2.5 billion by 2028, driven by increasing demand.

Global Throughput Single Cell Sequencing Market Value Is Forecast To Reach By 2034 With CAGR

Throughput Single Cell Sequencing by Application (Cancer, Immunology, Neurology, Others), by Types (Equipment, Serve), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Throughput Single Cell Sequencing Market Size | CAGR 15.2 Forecast 2033

Global Throughput Single Cell Sequencing Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Throughput Single Cell Sequencing Market Overview

The Throughput Single Cell Sequencing market refers to the industry focused on developing and applying high-throughput sequencing technologies to analyze individual cells. As a rapidly evolving field, the Throughput Single Cell Sequencing market size is expected to experience significant growth, driven by its growth outlook and market forecast, which are integral to the industry expansion. The scope of this market encompasses various single cell sequencing technologies, including next-generation sequencing, single-cell RNA sequencing, and single-cell genomics, catering to diverse applications such as cancer research, immunology, and neurology. According to recent estimates, the current Throughput Single Cell Sequencing market size is approximately $1.3 billion. The market is anticipated to grow at a compound annual growth rate (CAGR) of 14.5% from 2026 to 2033, driven by macro drivers such as advancements in sequencing technologies, increasing research funding, and the rising prevalence of chronic diseases.

Loading chart…

Key forces shaping the Throughput Single Cell Sequencing industry include technology shifts towards more efficient and cost-effective sequencing methods, regulatory frameworks that support the adoption of single cell sequencing in clinical settings, and competitive intensity among market players. The largest region in the Throughput Single Cell Sequencing market is currently North America, while the fastest-growing region is anticipated to be the Asia-Pacific, driven by increasing investments in genomics research and the expanding presence of key market players. As the market continues to evolve, understanding these dynamics will be crucial for strategic planners, C-suite executives, and business development teams seeking to navigate the opportunities and challenges presented by the Throughput Single Cell Sequencing market.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	7.13 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	10x Genomics; BD; BGI; Singleron Bio; Seekgene; ThunderBio; Tenk Genomics; MobiDrop; BioMarker; Dynamic Biosystems; M20 Genomics; Illumina; QIAGEN; Q2 Solutions; Novogene; Oxford Nanopore Technologies; PacBio; Azenta Life Sciences; Jingxin Biotechnology; TaKaRa; Bio-Rad; Mission bio; Aksomics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Throughput Single Cell Sequencing market is poised for significant growth, driven by various factors. The market dynamics are intricately linked to the advancements in sequencing technologies, regulatory frameworks, and shifting demand patterns.

Growth Drivers2 items

Advances in single-cell sequencing technologies have improved the Throughput Single Cell Sequencing market size, enabling researchers to analyze individual cells with higher precision and speed, thereby driving the growth forecast.

Increasing demand for personalized medicine and precision diagnostics has led to a surge in the adoption of single-cell sequencing technologies, contributing to the expansion of the Throughput Single Cell Sequencing market.

Restraints2 items

High capital expenditure requirements for setting up single-cell sequencing facilities and the need for specialized bioinformatics expertise may hinder the growth of the Throughput Single Cell Sequencing market, particularly among small and medium-sized research institutions.

Stringent regulatory frameworks and standardization challenges may limit the adoption of single-cell sequencing technologies, affecting the overall growth forecast of the Throughput Single Cell Sequencing market size.

Opportunities2 items

The integration of single-cell sequencing with artificial intelligence and machine learning can unlock new avenues for Throughput Single Cell Sequencing market growth, enabling researchers to analyze complex datasets and identify novel biomarkers.

The increasing focus on cancer research and immunology presents significant opportunities for the adoption of single-cell sequencing technologies, driving the expansion of the Throughput Single Cell Sequencing market and contributing to the growth forecast.

Challenges2 items

The Throughput Single Cell Sequencing market faces challenges related to data management and analysis, as the vast amounts of data generated by single-cell sequencing technologies require specialized bioinformatics tools and expertise.

The need for standardization and harmonization of single-cell sequencing protocols and data analysis pipelines poses a significant challenge, affecting the comparability and reliability of results across different research studies and institutions.

Market Segmentation

Loading chart…

The Throughput Single Cell Sequencing segmentation by application is a crucial aspect of understanding the market. This segment is divided into subtypes, including single-cell genomics, single-cell epigenomics, and single-cell transcriptomics. Each of these subtypes contributes significantly to the overall market size, with single-cell genomics holding a substantial share due to its widespread adoption in research and diagnostic applications.

The Types segment in the Throughput Single Cell Sequencing market includes low-throughput and high-throughput sequencing. High-throughput sequencing is further subdivided into moderate-throughput and ultra-high-throughput sequencing. The high-throughput sequencing subtype dominates the market due to its ability to process large numbers of samples quickly and accurately, making it an essential tool in research and clinical settings.

Throughput Single Cell Sequencing Segmentation Breakdown8 items

Application

Cancer

Immunology

Neurology

Others

Types

Equipment

Serve

Regional Insights

Loading chart…

The Throughput Single Cell Sequencing market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of single cell sequencing technologies, favorable policies, and significant investments in research and development.

Key drivers for each region include: for North America, infrastructure maturity, ecosystem development, and high demographics; for Europe, strong research initiatives, collaborative partnerships, and growing demand; for Asia Pacific, increasing government support, rising awareness, and expanding applications; for Latin America, emerging markets, improving access to sequencing technologies, and growing interest in precision medicine; and for Middle East & Africa, developing infrastructure, growing investment in healthcare, and increasing focus on genomics research.

The regional forecast indicates that the Throughput Single Cell Sequencing market will experience significant growth, driven by the increasing need for personalized medicine, advances in sequencing technologies, and growing demand for genomic analysis. Understanding the regional dynamics and key drivers is crucial for stakeholders to navigate the market and capitalize on emerging opportunities.

Competitive Landscape

The Throughput Single Cell Sequencing market is moderately consolidated, driven by a mix of global players and local companies. The Throughput Single Cell Sequencing competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and customization to cater to specific customer needs.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To mitigate these risks, companies focus on technology advancements, service model enhancements, channel strength, and cost advantages. The following companies have distinct strategic focuses:

10x Genomics: innovation pipeline

Illumina: premium pricing

Oxford Nanopore Technologies: regional expansion

PacBio: vertical integration

BD: OEM tie-ups

Singleron Bio: local manufacturing

Key Throughput Single Cell Sequencing Companies23 items

10x Genomics

BGI

Singleron Bio

Seekgene

ThunderBio

Tenk Genomics

MobiDrop

BioMarker

Dynamic Biosystems

M20 Genomics

Illumina

QIAGEN

Q2 Solutions

Novogene

Oxford Nanopore Technologies

PacBio

Azenta Life Sciences

Jingxin Biotechnology

TaKaRa

Bio-Rad

Mission bio

Aksomics

Market Ecosystem

The Throughput Single Cell Sequencing ecosystem encompasses a complex network of upstream, midstream, and downstream participants, creating and capturing value through the development, integration, and application of single cell sequencing technologies. Technology providers and suppliers form the upstream foundation, while integrators and channels facilitate the midstream, ultimately serving end users in the downstream segment. A comprehensive value chain analysis is essential to understand the intricacies of this ecosystem.

Raw material/component suppliers — provide sequencing reagents

Technology providers — develop sequencing platforms

OEMs / manufacturers — produce sequencing instruments

System integrators / EPCs — integrate sequencing systems

Distributors / channel partners — supply sequencing products

Service providers / after-sales — offer sequencing support services

End users / buyers — apply single cell sequencing technologies

In the Throughput Single Cell Sequencing ecosystem, control points are primarily held by technology providers and end users, as they influence adoption and drive demand. Dependency risks arise from input constraints, such as access to high-quality sequencing reagents, and standards approvals, which can impact the development and commercialization of sequencing technologies. Switching costs and interoperability requirements also play a crucial role, as end users often invest heavily in specific sequencing platforms and may face significant costs when transitioning to alternative technologies. The ecosystem's dynamics can vary by region, with different regulatory environments and market demands shaping the development and application of single cell sequencing technologies.

Recent Industry Insights

The Throughput Single Cell Sequencing industry has witnessed significant developments over the last 12-18 months, shaping the Throughput Single Cell Sequencing industry trends. Notable partnerships have been formed, such as collaborations between leading sequencing technology providers and research institutions, to advance the field of single-cell analysis. Furthermore, there have been strategic mergers and acquisitions, aiming to enhance product portfolios and expand market presence. Recent product launches have also focused on improving sequencing efficiency and accuracy, catering to the growing demand for high-throughput single-cell sequencing solutions.

Additionally, regulatory changes have supported the adoption of single-cell sequencing technologies in various applications, including cancer research and personalized medicine. The shift in consumer and enterprise trends towards more precise and targeted therapies has driven the demand for single-cell sequencing solutions. Funding rounds and expansions have also been announced, providing a boost to the development of innovative sequencing technologies and fueling the growth of the Throughput Single Cell Sequencing market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Throughput Single Cell Sequencing market. The market attractiveness is high due to the growing demand for precision medicine and the increasing adoption of single-cell sequencing technologies. The competitive intensity is moderate, with key players investing heavily in research and development to improve sequencing throughput and accuracy. The long-term outlook for the Throughput Single Cell Sequencing market outlook is positive, driven by advancements in innovation and the expanding applications of single-cell sequencing.

The innovation landscape is dynamic, with emerging technologies such as nanopore sequencing and single-molecule real-time sequencing expected to further boost market growth. However, the demand-supply balance may be challenged by the high cost of sequencing platforms and the need for specialized expertise. Key risk factors include regulatory changes and technological disruptions, which could impact market growth and competitiveness.

11 items

1. Executive Summary

2. Throughput Single Cell Sequencing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Throughput Single Cell Sequencing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Throughput Single Cell Sequencing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cancer

6.1.2. Immunology

6.1.3. Neurology

6.1.4. Others

6.2. Global Throughput Single Cell Sequencing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Equipment

6.2.2. Serve

6.3. Global Throughput Single Cell Sequencing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Throughput Single Cell Sequencing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Throughput Single Cell Sequencing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Throughput Single Cell Sequencing Market Competition by Key Manufacturers

8.1. Global Throughput Single Cell Sequencing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Throughput Single Cell Sequencing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. 10x Genomics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BGI

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Singleron Bio

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Seekgene

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ThunderBio

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Tenk Genomics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. MobiDrop

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. BioMarker

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Dynamic Biosystems

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. M20 Genomics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Illumina

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. QIAGEN

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Q2 Solutions

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Novogene

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Oxford Nanopore Technologies

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. PacBio

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Azenta Life Sciences

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Jingxin Biotechnology

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. TaKaRa

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Bio-Rad

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Mission bio

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Aksomics

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Throughput Single Cell Sequencing Market

Figure 4: Global Throughput Single Cell Sequencing Market: Drivers

Figure 5: Global Throughput Single Cell Sequencing Market: Challenges

Figure 6: Global Throughput Single Cell Sequencing Market: Trends

Figure 7: Global Throughput Single Cell Sequencing Market: Opportunity

Figure 8: Global Throughput Single Cell Sequencing Market: Restraint

Figure 9: Global Throughput Single Cell Sequencing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Throughput Single Cell Sequencing Market Value (USD Million) By Region

Figure 15: Global Throughput Single Cell Sequencing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Throughput Single Cell Sequencing Market Value (USD Million) By Region

Figure 23: Global Throughput Single Cell Sequencing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

99 items

Table 1: Market Segmentation Analysis

Table 2: Global Throughput Single Cell Sequencing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Throughput Single Cell Sequencing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Throughput Single Cell Sequencing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Throughput Single Cell Sequencing Market Value (USD Million) By Region

Table 10: Global Throughput Single Cell Sequencing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Throughput Single Cell Sequencing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Throughput Single Cell Sequencing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Throughput Single Cell Sequencing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: 10x Genomics Basic Information And Sales Area

Table 31: 10x Genomics. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: BGI Basic Information And Sales Area

Table 35: BGI. Products Portfolio

Table 36: Singleron Bio Basic Information And Sales Area

Table 37: Singleron Bio. Products Portfolio

Table 38: Seekgene Basic Information And Sales Area

Table 39: Seekgene. Products Portfolio

Table 40: ThunderBio Basic Information And Sales Area

Table 41: ThunderBio. Products Portfolio

Table 42: Tenk Genomics Basic Information And Sales Area

Table 43: Tenk Genomics. Products Portfolio

Table 44: MobiDrop Basic Information And Sales Area

Table 45: MobiDrop. Products Portfolio

Table 46: BioMarker Basic Information And Sales Area

Table 47: BioMarker. Products Portfolio

Table 48: Dynamic Biosystems Basic Information And Sales Area

Table 49: Dynamic Biosystems. Products Portfolio

Table 50: M20 Genomics Basic Information And Sales Area

Table 51: M20 Genomics. Products Portfolio

Table 52: Illumina Basic Information And Sales Area

Table 53: Illumina. Products Portfolio

Table 54: QIAGEN Basic Information And Sales Area

Table 55: QIAGEN. Products Portfolio

Table 56: Q2 Solutions Basic Information And Sales Area

Table 57: Q2 Solutions. Products Portfolio

Table 58: Novogene Basic Information And Sales Area

Table 59: Novogene. Products Portfolio

Table 60: Oxford Nanopore Technologies Basic Information And Sales Area

Table 61: Oxford Nanopore Technologies. Products Portfolio

Table 62: PacBio Basic Information And Sales Area

Table 63: PacBio. Products Portfolio

Table 64: Azenta Life Sciences Basic Information And Sales Area

Table 65: Azenta Life Sciences. Products Portfolio

Table 66: Jingxin Biotechnology Basic Information And Sales Area

Table 67: Jingxin Biotechnology. Products Portfolio

Table 68: TaKaRa Basic Information And Sales Area

Table 69: TaKaRa. Products Portfolio

Table 70: Bio-Rad Basic Information And Sales Area

Table 71: Bio-Rad. Products Portfolio

Table 72: Mission bio Basic Information And Sales Area

Table 73: Mission bio. Products Portfolio

Table 74: Aksomics Basic Information And Sales Area

Table 75: Aksomics. Products Portfolio

Table 76: Global Market Value (USD Million) (2025-2032) By Application

Table 77: Global Market Share (%) By Application (2032)

Table 78: Global Market Value (USD Million) (2025-2032) By Types

Table 79: Global Market Share (%) By Types (2032)

Table 80: Global Throughput Single Cell Sequencing Market Value (USD Million) By Region

Table 81: Global Throughput Single Cell Sequencing Market Share (%) By Region (2025-2032)

Table 82: North America Market Value (USD Million) (2025-2032) By Country

Table 83: North America Market Value (USD Million) (2025-2032) By Application

Table 84: North America Market Value (USD Million) (2025-2032) By Types

Table 85: Europe Market Value (USD Million) (2025-2032) By Country

Table 86: Europe Market Value (USD Million) (2025-2032) By Application

Table 87: Europe Market Value (USD Million) (2025-2032) By Types

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 91: South America Market Value (USD Million) (2025-2032) By Country

Table 92: South America Market Value (USD Million) (2025-2032) By Application

Table 93: South America Market Value (USD Million) (2025-2032) By Types

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 97: Research Programs/Design For This Report

Table 98: Key Data Information From Secondary Sources

Table 99: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Throughput Single Cell Sequencing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	7.13 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	10x Genomics; BD; BGI; Singleron Bio; Seekgene; ThunderBio; Tenk Genomics; MobiDrop; BioMarker; Dynamic Biosystems; M20 Genomics; Illumina; QIAGEN; Q2 Solutions; Novogene; Oxford Nanopore Technologies; PacBio; Azenta Life Sciences; Jingxin Biotechnology; TaKaRa; Bio-Rad; Mission bio; Aksomics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options